Investegate |Angelfish Inv PLC Announcements | Angelfish Inv PLC: RESULT OF GENERAL MEETING AND PROPOSALS investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
A year of COVID-19: the healthcare industry proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
I think this UK small-cap stock is just getting started
More on:
Sensyne Health
(LSE: SENS) and reckon it has lots of potential. The shares have been rising on the back on recent positive news.
I think the company is just getting started and I’d buy the stock in my portfolio. Here’s why.
US$12.3 TRILLION out of thin air…
And if you click here we’ll show you something that could be key to unlocking 5G’s full potential.
Sensyne Health: what does it do?
In a nutshell, Sensyne Health is an
AIM-listed healthcare company that uses artificial intelligence to analyse data. The company operates two divisions Discovery Sciences and Software Products.
Demand for workspace rapid Covid tests jumps as offices prepare to reopen
Demand for workspace Covid tests has increased as businesses, spurred on by the government s roadmap, prepare to open. (Photo by Finnbarr Webster/Getty Images)
Diagnostics company Excalibur Healthcare, which provide fast-acting lateral flow tests, said demand had increased for its test and it had seen a surge in calls from companies wanting to implement workplace testing regimes.
Excalibur sold hundreds of thousands of lateral flow tests in the seven days after Boris Johnson announced his roadmap out of lockdown.
Excalibur’s chief executive and founder Sir Chris Evans said: “We have new firms contacting us and are adding new customers every single week or day. Everybody now realises they will need to test. They are desperate and as soon as they can open up, they will.”